IFIH1 and rheumatoid arthritis: The clinical characteristics of the patients with DM and SLE are shown in Table 1 (details of this anti-MDA5+ DM patient cohort had been reported previously (16) and data for other disease controls including ASyS, RA, and SSc are in Table 2).